Psychedelic Drugs Market Report 2023

Psychedelic Drugs Global Market Report 2023 – By Type (Lysergic Acid Diethylamid (LSD) Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB) Salvia), By Disease Indication (Depression, PTSD), By Origin (Natural, Synthetic), By Application (Treatment Resistant Depression, Opiate addiction, Post Traumatic Stress Disorder, Narcolepsy, Panic Disorders), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | Delivery Time: 2-3 business days | Format :

Need assistance or more information before the purchase?

Enquire Before Buying
Psychedelic Drugs Market

Proud Members Of

Psychedelic drug refers to a group of psychoactive drugs that alter perception, mood, and thought processes. All of the senses are affected by psychedelics, which change a person's thinking, perception of time, and emotions. These include chemicals such as Lysergic acid diethylamid (LSD) and plants such as peyote. These medications are used to treat a variety of brain conditions.

The main types of psychedelic drugs are lysergic acid diethylamid, ketamine, phencyclidine, gamma-hydroxybutyric acid (GHB), and salvia. Lysergic Acid Diethylamide (LSD) is also known colloquially as acid. LSD is manufactured in crystalline form and then mixed with other inert ingredients or diluted as a liquid to produce an ingestible form. The various disease indications include depression and PTSD, which could be natural or synthetic. The numerous applications include treatment-resistant depression, opiate addiction, post-traumatic stress disorder, narcolepsy, and panic disorders, and are distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

The global psychedelic drugs market is segmented -

1) By Type: Lysergic Acid Diethylamid (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

The global psychedelic drugs market size will grow from $4.2 billion in 2022 to $4.83 billion in 2023 at a compound annual growth rate (CAGR) of 14.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the psychedelic drugs is expected to grow to $8.31 billion in 2027 at a CAGR of 14.5%.

The increase in the cases of mental illnesses is expected to propel the growth of the psychedelic drugs market going forward. Mental illnesses refer to health conditions involving changes in emotion, thinking, or behavior. Mental illnesses include conditions such as distress and post-traumatic stress disorder. Psychedelic drugs are used to treat depression and post-traumatic stress disorder, and their regular usage decreases mental illnesses. For instance, in 2020, according to the National Alliance on Mental Illness (NAMI), a US-based mental health organization, 21% of adults in America were suffering from mental illness in 2020, which amounted to 52.9 million people. Therefore, an increase in the number of cases of mental illnesses is driving the growth of the psychedelic drugs market.

Major players in the psychedelic drugs market are Johnson & Johnson, Pfizer, Hikma Pharmaceuticals PLC, Roche Holding AG, Merck & Co Inc., Jazz Pharmaceuticals plc, COMPASS Pathways PLC, Celon Pharma S.A., Numinus Wellness Inc., AbbVie, Mylan N.V., Avadel, NeuroRx Inc., Klarisana, AstraZeneca, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Allergan Inc., Mota Ventures Corp., Seelos Therapeutics, Emmes Company, and Novatris International AG.

The introduction of "depression spray" is the key trend gaining popularity in the psychedelic drug market. Major companies operating in the psychedelic drug market are introducing nasal spray drugs for major depressive disorders to sustain their position in the market. For instance, in August 2021, Hikma Pharmaceuticals plc, a UK based pharmaceutical company, launched KLOXXADO. KLOXXADO is an 8 mg nasal spray containing naloxone HCl. This spray is used for the immediate care of patients, both adults and children, with known or suspected opioid overdoses, as shown by respiratory depression and/or central nervous system depression.

In April 2022, Numinus, a Canada-based company that manufactures psychedelic medicine with holistic, integrated psychotherapy, acquired Novamind for a deal amount of $20.77 million. With this acquisition, Numinus is expected to expand its psychotherapy clinics in the US and develop advanced psychedelic programs. Novamind is a US-based mental health company and manufacturer of psychedelic medicine.

North America was the largest region in the psychedelic drugs market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the psychedelic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The psychedelic drugs market consists of sales of psilocybin, PCP, cannabis, and ecstasy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The psychedelic drugs market research report is one of a series of new reports from The Business Research Company that provides psychedelic drugs market statistics, including psychedelic drugs industry global market size, regional shares, competitors with a psychedelic drugs market share, detailed psychedelic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the psychedelic drugs industry. This psychedelic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Psychedelic Drugs Market Characteristics

    3. Psychedelic Drugs Market Trends And Strategies

    4. Psychedelic Drugs Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Psychedelic Drugs Market

    4.2 Ukraine-Russia War Impact On Psychedelic Drugs Market

    4.3 Impact Of High Inflation On Psychedelic Drugs Market

    5. Psychedelic Drugs Market Size And Growth

    5.1. Global Psychedelic Drugs Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Psychedelic Drugs Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Psychedelic Drugs Market Segmentation

    6.1. Global Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    Lysergic Acid Diethylamid (LSD)

    Ketamine

    Phencyclidine

    Gamma Hydroxybutyric Acid (GHB)

    Salvia

    6.2. Global Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    Depression

    PTSD

    6.3. Global Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    Natural

    Synthetic

    6.4. Global Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    Treatment Resistant depression

    Opiate addiction

    Post- Traumatic stress disorder

    Narcolepsy

    Panic Disorders

    6.5. Global Psychedelic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    Hospitals Pharmacy

    Retail Pharmacy

    Online Pharmacy

    7. Psychedelic Drugs Market Regional And Country Analysis

    7.1. Global Psychedelic Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    7.2. Global Psychedelic Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    8. Asia-Pacific Psychedelic Drugs Market

    8.1. Asia-Pacific Psychedelic Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    8.3. Asia-Pacific Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    9. China Psychedelic Drugs Market

    9.1. China Psychedelic Drugs Market Overview

    9.2. China Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F,$ Billion

    9.3. China Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F,$ Billion

    10. India Psychedelic Drugs Market

    10.1. India Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    10.2. India Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    11. Japan Psychedelic Drugs Market

    11.1. Japan Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    11.2. Japan Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    12. Australia Psychedelic Drugs Market

    12.1. Australia Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    12.2. Australia Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    13. Indonesia Psychedelic Drugs Market

    13.1. Indonesia Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    13.2. Indonesia Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    14. South Korea Psychedelic Drugs Market

    14.1. South Korea Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    14.2. South Korea Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    15. Western Europe Psychedelic Drugs Market

    15.1. Western Europe Psychedelic Drugs Market Overview

    15.2. Western Europe Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    15.3. Western Europe Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    16. UK Psychedelic Drugs Market

    16.1. UK Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    16.2. UK Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    17. Germany Psychedelic Drugs Market

    17.1. Germany Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    17.2. Germany Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    18. France Psychedelic Drugs Market

    18.4. France Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    18.5. France Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    19. Eastern Europe Psychedelic Drugs Market

    19.1. Eastern Europe Psychedelic Drugs Market Overview

    19.2. Eastern Europe Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    19.3. Eastern Europe Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    20. Russia Psychedelic Drugs Market

    20.1. Russia Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    20.2. Russia Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    21. North America Psychedelic Drugs Market

    21.1. North America Psychedelic Drugs Market Overview

    21.2. North America Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    21.3. North America Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    22. USA Psychedelic Drugs Market

    22.1. USA Psychedelic Drugs Market Overview

    22.2. USA Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    22.3. USA Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    23. South America Psychedelic Drugs Market

    23.1. South America Psychedelic Drugs Market Overview

    23.2. South America Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    23.3. South America Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    24. Brazil Psychedelic Drugs Market

    24.1. Brazil Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    24.2. Brazil Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    25. Middle East Psychedelic Drugs Market

    25.1. Middle East Psychedelic Drugs Market Overview

    25.2. Middle East Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    25.3. Middle East Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    26. Africa Psychedelic Drugs Market

    26.1. Africa Psychedelic Drugs Market Overview

    26.2. Africa Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    26.3. Africa Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion

    27. Psychedelic Drugs Market Competitive Landscape And Company Profiles

    27.1. Psychedelic Drugs Market Competitive Landscape

    27.2. Psychedelic Drugs Market Company Profiles

    27.2.1. Johnson & Johnson

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Pfizer

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Hikma Pharmaceuticals PLC

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Roche Holding AG

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Merck & Co Inc

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Psychedelic Drugs Market

    29. Psychedelic Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 4: Global Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 5: Global Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 6: Global Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 7: Global Psychedelic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 8: Global Psychedelic Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 9: Global Psychedelic Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 11: Asia-Pacific, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 12: China, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 13: China, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 14: India, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 15: India, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 16: Japan, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 17: Japan, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 18: Australia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 19: Australia, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 20: Indonesia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 21: Indonesia, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 22: South Korea, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 23: South Korea, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 24: Western Europe, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 25: Western Europe, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 26: UK, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 27: UK, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 28: Germany, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 29: Germany, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 30: France, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 31: France, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 33: Eastern Europe, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 34: Russia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 35: Russia, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 36: North America, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 37: North America, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 38: USA, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 39: USA, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 40: South America, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 41: South America, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 42: Brazil, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 43: Brazil, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 44: Middle East, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 45: Middle East, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 46: Africa, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 47: Africa, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Table 48: Johnson & Johnson Financial Performance
  • Table 49: Pfizer Financial Performance
  • Table 50: Hikma Pharmaceuticals PLC Financial Performance
  • Table 51: Roche Holding AG Financial Performance
  • Table 52: Merck & Co Inc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 4: Global Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 5: Global Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 6: Global Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 7: Global Psychedelic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 8: Global Psychedelic Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 9: Global Psychedelic Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 11: Asia-Pacific, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 12: China, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 13: China, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 14: India, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 15: India, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 16: Japan, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 17: Japan, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 18: Australia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 19: Australia, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 21: Indonesia, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 22: South Korea, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 23: South Korea, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 25: Western Europe, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 26: UK, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 27: UK, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 28: Germany, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 29: Germany, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 30: France, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 31: France, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 33: Eastern Europe, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 34: Russia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 35: Russia, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 36: North America, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 37: North America, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 38: USA, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 39: USA, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 40: South America, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 41: South America, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 42: Brazil, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 43: Brazil, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 44: Middle East, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 45: Middle East, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 46: Africa, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 47: Africa, Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2027F, 2032F, $ Billion
  • Figure 48: Johnson & Johnson Financial Performance
  • Figure 49: Pfizer Financial Performance
  • Figure 50: Hikma Pharmaceuticals PLC Financial Performance
  • Figure 51: Roche Holding AG Financial Performance
  • Figure 52: Merck & Co Inc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report